Gene · 407019
Papers3,646
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,646
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Crosstalk between Non-Coding RNAs and Wnt/β-Catenin Signaling in Head and Neck Cancer: Identification of Novel Biomarkers and Therapeutic Agents. | Noncoding RNA | 2023 | 37888209 | PubTator, text mining | PubMed |
| Mutant p53 Gain-of-Function Induces Migration and Invasion through Overexpression of miR-182-5p in Cancer Cells. | Cells | 2023 | 37887350 | PubTator, text mining | PubMed |
| MicroRNAs Signature Panel Identifies Heavy Drinkers with Alcohol-Associated Cirrhosis from Heavy Drinkers without Liver Injury. | Biology (Basel) | 2023 | 37887024 | PubTator, text mining | PubMed |
| How Extracellular Nano-Vesicles Can Play a Role in Sepsis? An Evidence-Based Review of the Literature. | Int J Nanomedicine | 2023 | 37869065 | PubTator, text mining | PubMed |
| Diagnostic and treatment value of XPNPEP3 in acute myocardial infarction. | J Thorac Dis | 2023 | 37868889 | PubTator, text mining | PubMed |
| The role of noncoding RNAs in the tumor microenvironment of hepatocellular carcinoma. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37867435 | PubTator, text mining | PubMed |
| The Potential Hepatoprotective Effect of Vaccinium arctostaphylos L. Fruit Extract in Diabetic Rat. | Cell J | 2023 | 37865880 | PubTator, text mining | PubMed |
| Highly-Expressed MiR-221-3p Distinctly Increases the Incidence of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus. | Transl Vis Sci Technol | 2023 | 37856104 | PubTator, text mining | PubMed |
| MiR-423-5p as Optimal Endogenous Control for Quantification of Circulating MicroRNAs in Patients With CKD. | Kidney Int Rep | 2023 | 37849998 | PubTator, text mining | PubMed |
| The role of MicroRNA as a potential diagnostic and prognostic biomarker for cerebral aneurysms. | Neurosciences (Riyadh) | 2023 | 37844954 | PubTator, text mining | PubMed |
| Lipid metabolism as a target for cancer drug resistance: progress and prospects. | Front Pharmacol | 2023 | 37841917 | PubTator, text mining | PubMed |
| The mechanism of ferroptosis and its related diseases. | Mol Biomed | 2023 | 37840106 | PubTator, text mining | PubMed |
| High serum miR-223-3p expression level predicts complete response and prolonged overall survival in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation. | Front Oncol | 2023 | 37829335 | PubTator, text mining | PubMed |
| Extracellular vesicles in hematological malignancies: EV-dence for reshaping the tumoral microenvironment. | Front Immunol | 2023 | 37822925 | PubTator, text mining | PubMed |
| Serum polychlorinated biphenyl levels and circulating miRNAs in non-obese women with and without polycystic ovary syndrome. | Front Endocrinol (Lausanne) | 2023 | 37790603 | PubTator, text mining | PubMed |
| Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer. | Front Pharmacol | 2023 | 37781691 | PubTator, text mining | PubMed |
| The emerging role of lncRNAs in osteoarthritis development and potential therapy. | Front Genet | 2023 | 37779916 | PubTator, text mining | PubMed |
| STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia. | Signal Transduct Target Ther | 2023 | 37777506 | PubTator, text mining | PubMed |
| Novel Therapeutic Approaches to Prevent Atherothrombotic Ischemic Stroke in Patients with Carotid Atherosclerosis. | Int J Mol Sci | 2023 | 37762627 | PubTator, text mining | PubMed |
| Diagnosis, Progress, and Treatment Update of Kawasaki Disease. | Int J Mol Sci | 2023 | 37762250 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407019/papers?page=10